Clinical

 

Dapagliflozin Reduces Cardiovascular Risk in Diabetes Patients, Regardless of Baseline Kidney Function

April 14, 2021

An analysis of the DECLARE-TIMI 58 trial indicates the cardiovascular benefit of dapagliflozin use in patients with diabetes was consistent regardless of baseline kidney function and suggests the effects could be independent of glucose reduction.

CLARIFY: Diabetes Poses Major Risk in Patients with Coronary Syndromes

April 13, 2021

An analysis of the CLARIFY registry is providing clinicians with further insight into the impact of diabetes in patients with chronic coronary syndromes, particularly the increased risk of stroke, myocardial infarction, and cardiovascular death.

Case Report: Altered College Student

April 12, 2021

Our latest case report from Dr. Brady Pregerson features a 20 y/o female brought to the emergency department by EMS for altered mental status. Check out the EKG and see if you can determine the diagnosis.

Preterm Birth Associated with Increased Heart Failure Risk Throughout Adulthood

April 09, 2021

An analysis of nearly 4.2 million patients from a birth registry indicates being born preterm was linked to a significantly higher risk of developing heart failure during childhood and a 42% greater risk of heart failure in adulthood.